News

Post-CABG stroke risk same with one or two clamps

View on the News

Protecting the brain or the heart?

“A randomized trial is needed to answer the question, ‘Can CABG [coronary artery bypass grafting] be safely performed with either one or two aortic clamps in all patients?’ ” Dr. Jennifer S. Lawton said in her invited commentary (J. Thorac. Cardiovasc. Surg. 2015 [doi:10.1016/j.jtcvs.2015.05.002]).

Dr. Lawton acknowledged the positions that advocates of both techniques have staked out: advocates of the single-clamp (SC) technique prefer the ability to perform the proximal anastomoses without the added space constraints and reduced visibility of the partial clamp and moving heart; proponents of the partial-clamp (PC) method cite advantages in the ability to determine graft length with the full heart and the likelihood to reanimate the heart earlier to reduce the risk of a heart attack.

The PC technique required longer cardiopulmonary bypass time, 88.2 minutes vs. 73.7 minutes, but the SC group had longer cross-clamp times, 54.5. vs. 50.7 minutes. “The longer clamp time did not alter the outcomes reported (stroke and mortality) – although specific outcomes of myocardial injury including need for inotropes, troponin levels, myocardial infarction, etc. were not reported,” Dr. Lawton said. “Thus, the question for the surgeon is, ‘What is more important, the brain or the heart?’ ”

The results from Dr. Araque’s study “are valuable” because of the large patient cohort and the suggestion that “the use of a second clamp is not likely to significantly alter outcomes of stroke and mortality,” she wrote.

But their study leaves a few questions remaining, Dr. Lawton said. “What is the best treatment of high-risk patients who may benefit from limited aortic manipulation the most? Can two clamps be safely applied to all types of aortas? And does the risk of dissection go up with the use of two clamps?”

Although a randomized trial would be difficult because of the low risk of stroke in on-pump CABG, such a trial could answer those questions if it involved routine epiaortic ultrasound, Dr. Lawton said.

Dr. Lawton is professor of surgery in the division of cardiothoracic surgery at Washington University, St. Louis.


 

FROM THE JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

References

When performing on-pump coronary artery bypass grafting (CABG), cardiac surgeons can control very few factors to reduce the risk of stroke – with the exception of which method of aortic manipulation they use. Debate and controversy, however, have surrounded which aortic manipulation technique is best: single- or double-clamp occlusion.

A large retrospective study of almost 8,500 patients who had CABG at the Mayo Clinic in Rochester, Minn., over a 17-year period showed that, while use of the single-aortic cross-clamp (SC) technique steadily increased, the risk of stroke is virtually the same as it is with the partial aortic cross-clamp (PC), or double cross-clamp, technique. The study authors, led by Dr. Juan C. Araque, published their results online in the Journal of Thoracic and Cardiovascular Surgery (J. Thorac. Cardiovasc. Surg. 2015 [doi:10.1016/j.jtcvs.2015.04.010]).

“It is intuitive that less aortic manipulation would result in less risk of stroke,” Dr. Araque and colleagues said, but even off-pump CABG, which requires no aortic manipulation, is not without stroke risk.

“It is conceivable that there is some inherent risk of stroke associated with any cardiac operation, and that risk may increase with manipulation of the ascending aortic with the aortic cross clamp,” they wrote. “Our data would suggest, however, that the risk does not increase further with the additional aortic manipulation of the partial occlusion clamp.”

The study comes on the heels of a 2008 meta-analysis that found no benefit of SC in comparison to PC (Interact. Cardiovasc. Thorac. Surg. 2008;7:500-3), while another study in 2011 suggested that less aortic manipulation carried a significantly lower stroke risk (Heart Lung Circ. 2011;20:318-24).

The Mayo study evaluated the SC technique in 2,051 patients and PC in 6,446 patients who had isolated on-pump CABG between 1993 and 2010. The rate of stroke was 1.2% in the SC group and 1.5% among those who had PC. In two propensity-matched cohorts of 1,333 patients each, the stroke rate was 1.2% in each group. The investigators used the Society of Thoracic Surgeons’ risk calculator variables to create the propensity-matched cohorts.

The study group excluded high-risk patients, including those who had off-pump operations or previous cardiac surgeries or required replacement of a cross clamp during an unplanned operation.

The goal of the study was not to compare outcomes with the off-pump technique. “It is only to bring attention to the associated non-zero stroke rate with both techniques,” Dr. Araque and colleagues said.

Their findings are significant because on-pump CABG is the preferred operation of cardiac surgeons, accounting for more than 80% of the CABG operations in the SYNTAX study (N. Engl. J. Med. 2009;360:961-72). “The ‘anaortic’ off-pump technique may be a more specialized technique, representing less than 15% of operations in one large series,” Dr. Araque and coauthors said.

They acknowledged a few limitations resulting from the observational nature of the study, including that surgeons may have missed some strokes because they did not use a routine, standardized procedure for evaluating stroke signs along with the lack of documented assessment of the descending aorta. But they also stated that the large number of patients in the study, along with the use of propensity matching, addresses some of the bias inherent in an observational study.

The study authors disclosed no relationships.

Recommended Reading

Erectile dysfunction: New frontier in interventional cardiology
MDedge Cardiology
Perioperative factors influenced open TAAA repair
MDedge Cardiology
Elephant stent aorta repair – good outcomes, but is it too complex?
MDedge Cardiology
Monitoring effectively identifies seizures in postbypass neonates
MDedge Cardiology
FDA approves cangrelor, an intravenous antiplatelet drug
MDedge Cardiology
Idarucizumab reverses dabigatran’s anticoagulant effects
MDedge Cardiology
Two U.S. transcatheter valve approvals reshape TAVR
MDedge Cardiology
Older MI patients missing out on ICDs
MDedge Cardiology
ACC/HRS/SCAI seek to unify rollout of percutaneous LAA occlusion
MDedge Cardiology
SVS: Four easy preop variables predict mortality in ruptured AAAs
MDedge Cardiology